Epidemiology of rotavirus in India
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Rotavirus is the leading cause of childhood diarrhea worldwide, causing an estimated 600,000 deaths each year. To assess the potential benefits of a national rotavirus immunization program in India, we analyzed 40 published studies of rotavirus that were conducted between 1976 and 1997 and included a total of approximately 13,000 Indian pediatric inpatients. Pediatric studies featuring 100 or more patients and lasting at least 12 months in duration and all neonatal studies were analyzed. Rotavirus was detected in a median of 18% of pediatric patients and 28% of neonates surveyed. Fifty percent of all children hospitalized with rotavirus by age 5 were hospitalized by the age of 6 months, 75% by the age of 9 months, and almost 100% by the age of 2 years. Rotavirus was most prevalent (31%) in children between 7 and 12 months of age, followed by children between 1 and 2 years of age (20%), and children <7 months of age (13%). VP7 genotypes G1 and G2 were most commonly isolated although significant heterogeneity of serotypes was observed. P, G9 strains were most frequently isolated among neonates. In 1998; approximately 98,000 childhood deaths were caused by rotavirus. These data underscore the urgent need for safe and effective interventions against rotavirus such as vaccines. The significant diversity of rotavirus strains and young age of hospitalization pose unique challenges to the formulation of a rotavirus immunization program in India, but raise the possibility of utilizing a neonatal vaccine to provide effective coverage.
- Bern C, Martines J, deZoysa I, Glass RI. The magnitude of the global problem of diarrhoeal disease: a ten-year update.Bull World Health Organ 1992;70:705–714.
- Glass RI, Bresee JS, Parashar U, Miller M, Gentsch JR. Rotavirus vaccines at the threshold.Nature Med 1997;3(12): 1324–1325. CrossRef
- Bhan MK, Lew JF, Sazawal S, Das BK, Gentsch JR, Glass RI. Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea.J Infect Dis 1993;168(2):282–287.
- Cicirello HG, Das BK, Gupta A, Bhan MK, Gentsch JR, Kumar Ret al. High prevalence of rotavirus infection among neonates born at hospitals in Delhi, India: predisposition of newborns for infection with unusual rotavirus.Pediatr Infect Dis J 1994 13(8):720–724. CrossRef
- Jayashree S, Bhan MK, Raj P, Kumar R, Svensson L, Stintzing Get al. Neonatal rotavirus infection and its relation to cord blood antibodies.Scand J Infect Dis 1988;20(3):249–253. CrossRef
- Jesudoss ES, John TJ, Maiya PP, Jadhav M, Spence L. Prevalence of rotavirus infection in neonates.Indian J Med Res 1979;70:863–867.
- Das BK, Kumar RK, Bhan MK. Rotavirus gastroenteritis and vaccine development.Indian J Pediatr 1998;65:S36-S44.
- Ramachandran M, Das BK, Vij A, Kumar R, Bhambal SS, Kesari Net al. Unusual diversity of human rotavirus G and P genotypes in India.J Clin Microbiol 1996;34(2):436–439.
- Epidemiology of rotavirus in India
The Indian Journal of Pediatrics
Volume 68, Issue 9 , pp 855-862
- Cover Date
- Print ISSN
- Online ISSN
- Springer India
- Additional Links
- Immunization programe
- Industry Sectors
- Author Affiliations
- 1. Viral Gastroenteritis Section, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
- 2. Stanford University School of Medicine, Stanford, California, USA
- 3. Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, 110 029, New Delhi, India